Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
NCT02141022 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2016-05-10
Summary
This study is investigating the efficacy of computer-based cognitive exercises as a means of cognitive remediation in patients with Multiple Sclerosis (MS) who are beginning the disease modifying pharmacotherapy Gileyna.
Conditions
- Multiple Sclerosis
- Cognitive Deficits
- Gilenya Modifying Therapy for MS
Interventions
- OTHER
-
plasticity-based computerized cognitive remediation program
- DRUG
-
Gileyna
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Lauren Krupp, M.D. · Stony Brook University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2014-09-30
- Completion
- 2015-09-30
Countries
- United States
Study Locations
More Related Trials
-
Intellectual Enrichment to Build Cognitive Reserve in MS
NCT01978574 ·Status: COMPLETED ·Phase: NA
-
Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis
NCT05562414 ·Status: UNKNOWN ·Phase: NA
-
Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya
NCT02137707 ·Status: COMPLETED
-
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
NCT01194570 ·Status: COMPLETED ·Phase: PHASE3
-
Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)
NCT00695084 ·Status: COMPLETED ·Phase: PHASE1
-
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
NCT07207148 ·Status: RECRUITING
-
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
NCT04233970 ·Status: COMPLETED ·Phase: NA
-
CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy
NCT05131828 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of PoNS in Reducing Symptoms of Multiple Sclerosis
NCT04496531 ·Status: COMPLETED ·Phase: NA
-
Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab
NCT04377555 ·Status: COMPLETED ·Phase: PHASE4
-
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
NCT00930553 ·Status: COMPLETED ·Phase: PHASE3
-
Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury
NCT04408274 ·Status: COMPLETED ·Phase: NA
-
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
NCT07221799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis
NCT02612935 ·Status: COMPLETED
-
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
NCT00881205 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS
NCT02048072 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
NCT01811290 ·Status: UNKNOWN
-
Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
NCT05902429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Measuring Active Microglia in Progressive Multiple Sclerosis
NCT02207075 ·Status: COMPLETED
-
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis (Feasibility Study)
NCT04057066 ·Status: COMPLETED ·Phase: NA
-
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
NCT06283524 ·Status: COMPLETED
-
A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01037907 ·Status: TERMINATED ·Phase: PHASE2
-
A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis
NCT01142583 ·Status: COMPLETED
-
Effects of Resistance Training in Multiple Sclerosis: a Randomized Trial.
NCT06478784 ·Status: RECRUITING ·Phase: NA
-
CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis
NCT05671055 ·Status: COMPLETED